Eyre Peninsula residents living with secondary progressive multiple sclerosis may soon have access to a new treatment option, following its approval here in Australia.
MS is a chronic disorder of the central nervous system which currently affects more than 25,000 Australians.
The secondary progressive stage of the condition is often characterised by physical and cognitive changes, as well as an accumulation of disability.
Associate Professor Anneke van der Walt says the approval of Mayzent is welcome news for those who are living with the debilitating condition.
“For any local residents with MS I would advise them to engage and see a neurologist and if they don’t have one, they should reengage with their local doctor and get a referral to see if the new treatment will be of benefit to them.” Said Professor Anneke.